Ana Paula de Azambuja

Mrs. Ana Paula de Azambuja

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Blood
Verified
Journal Article
Open access
FGFernanda Gutierrez-Rodrigues
Fernanda Gutierrez-Rodrigues
EGEmma M. Groarke
Emma M. Groarke
NTNatthakan Thongon
Natthakan Thongon
JRJuan Jose Rodriguez-Sevilla
Juan Jose Rodriguez-Sevilla
LCLuiz Fernando B. Catto
Luiz Fernando B. Catto
RCRodrigo T. Calado
Rodrigo T. Calado
Telomere biology disorders (TBDs), caused by pathogenic germ line variants in telomere-related genes, present with multiorgan disease and a predisposition to cancer. Clonal hematopoiesis (CH) as a marker of cancer development and survival in TBDs is poorly understood. Here, we characterized the clonal landscape of a large cohort of 207 patients with TBD with a broad range of age and phenotype. CH occurred predominantly in symptomatic patients and in signature genes typically associated with cancers: PPM1D, POT1, TERT promoter (TERTp), U2AF1S34, and/or TP53. Chromosome 1q gain (Chr1q+) was the commonest karyotypic abnormality. Clinically, multiorgan involvement and CH in TERTp, TP53, and splicing factor genes were associated with poorer overall survival. Chr1q+ and splicing factor or TP53 mutations significantly increased the risk of hematologic malignancies, regardless of clonal burden. Chr1q+ and U2AF1S34 mutated clones were premalignant events associated with the secondary acquisition of mutations in genes related to hematologic malignancies. Similar to the known effects of Chr1q+ and TP53-CH, functional studies demonstrated that U2AF1S34 mutations primarily compensated for aberrant upregulation of TP53 and interferon pathways in telomere-dysfunctional hematopoietic stem cells, highlighting the TP53 pathway as a canonical route of malignancy in TBD. In contrast, somatic POT1/PPM1D/TERTp mutations had distinct trajectories unrelated to cancer development. With implications beyond TBD, our data show that telomere dysfunction is a strong selective pressure for CH. In TBD, CH is a poor prognostic marker associated with worse overall survival. The identification of key regulatory pathways that drive clonal transformation in TBD allows for the identification of patients at a higher risk of cancer development.

21 October 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
KEKieren J Egan
Kieren J Egan
Malcolm von SchantzMalcolm von Schantz
Malcolm von Schantz
ANAndré B Negrão
André B Negrão
HSHadassa C Santos
Hadassa C Santos
AHAndréa R V R Horimoto
Andréa R V R Horimoto
APAlexandre C Pereira
Alexandre C Pereira
Purpose Cardiovascular disease (CVD) is a major challenge to global health. The same epidemiological transition scenario is replayed as countries develop, but with variations based on environment, culture and ethnic mixture. The Baependi Heart Study was set up in 2005 to develop a longitudinal family-based cohort study that reflects on some of the genetic and lifestyle-related peculiarities of the Brazilian populations, in order to evaluate genetic and environmental influences on CVD risk factor traits. Participants Probands were recruited in Baependi, a small rural town in the state of Minas Gerais, Brazil, following by first-degree and then increasingly more distant relatives. The first follow-up wave took place in 2010, and the second in 2016. At baseline, the study evaluated 1691 individuals across 95 families. Cross-sectional data have been collected for 2239 participants. Findings to date Environmental and lifestyle factors and measures relevant to cardiovascular health have been reported. Having expanded beyond cardiovascular health outcomes, the phenotype datasets now include genetics, biochemistry, anthropometry, mental health, sleep and circadian rhythms. Many of these have yielded heritability estimates, and a shared genetic background of anxiety and depression has recently been published. In spite of universal access to electricity, the population has been found to be strongly shifted towards morningness compared with metropolitan areas. Future plans A new follow-up, marking 10 years of the study, is ongoing in 2016, in which data are collected as in 2010 (with the exception of the neuropsychiatric protocol). In addition to this, a novel questionnaire package collecting information about intelligence, personality and spirituality is being planned. The data set on circadian rhythms and sleep will be amended through additional questionnaires, actimetry, home sleep EEG recording and dim light melatonin onset (DLMO) analysis. Finally, the anthropometric measures will be expanded by adding three-dimensional facial photography, voice recording and anatomical brain MRI.

21 November 2020 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
MIMaura Rosane Valério Ikoma-Colturato
Maura Rosane Valério Ikoma-Colturato
MBMiriam P. Beltrame
Miriam P. Beltrame
FFFelipe M. Furtado
Felipe M. Furtado
GPGlicinia Pimenta
Glicinia Pimenta
ECElaine Sobral da Costa
Elaine Sobral da Costa
MYMihoko Yamamoto
Mihoko Yamamoto
The minimal residual disease (MRD) status plays a crucial role in the treatment of acute lymphoblastic leukemia (ALL) and is currently used in most therapeutic protocols to guide the appropriate therapeutic decision. Therefore, it is imperative that laboratories offer accurate and reliable results through well standardized technical processes by establishing rigorous operating procedures. Our goal is to propose a monoclonal antibody (MoAb) panel for MRD detection in ALL and provide recommendations intended for flow cytometry laboratories that work on 4-color flow cytometry platforms. The document includes pre-analytical and analytical procedures, quality control assurance, technical procedures, as well as the information that needs to be included in the reports for clinicians.

2 April 2019 in Cells
Verified
Journal Article
Open access
PDF file
ARAline Rangel-Pozzo
Aline Rangel-Pozzo
DSDaiane Corrêa de Souza
Daiane Corrêa de Souza
ASAna Teresa Schmid-Braz
Ana Teresa Schmid-Braz
AAAna Paula de Azambuja
Ana Paula de Azambuja
TFThais Ferraz-Aguiar
Thais Ferraz-Aguiar
SMSabine Mai
Sabine Mai
The disease course of myelodysplastic syndromes (MDS) features chromosome instability and clonal evolution, leading to the sequential acquisition of novel cytogenetic aberrations and the accumulation of these abnormalities in the bone marrow. Although clonal cytogenetic abnormalities can be detected by conventional cytogenetics in 50% of patients with MDS, such distinguishing patterns are lacking in the other 50%. Despite the increase in the prognostic value of some biomarkers, none of them is specific and able to discriminate between stable and unstable patients that subsequently progress to acute myeloid leukemia. This pilot study aimed to investigate the potential use of the 3D telomere profiling to detect genomic instability in MDS patients with or without clonal cytogenetic evolution. The comparison between different time points in patients with cytogenetic changes showed that in the CD34+ MDS cells, there was a significant decrease in the total number of telomeric signals, the average intensity of signals and the total intensity of telomeres. By contrast, the number of aggregates increased during cytogenetic evolution (p < 0.001). This pattern was observed only for MDS patients with cytogenetic evolution but was absent in patients without cytogenetic changes. In conclusion, we demonstrated that the 3D nuclear telomere organization was significantly altered during the MDS disease course, and may have contributed to cytogenetic clonal evolution.

11 May 2021 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
SCSamuel Ricardo Comar
Samuel Ricardo Comar
BSBeatriz Sanada Spiri
Beatriz Sanada Spiri
DFDiésica Suiane Ferreira
Diésica Suiane Ferreira
AAAna Paula de Azambuja
Ana Paula de Azambuja

12 October 2022 in British Journal of Haematology
Verified
Journal Article
Open access
MIMaura Rosane Valério Ikoma-Colturato
Maura Rosane Valério Ikoma-Colturato
CBCamila M. Bertolucci
Camila M. Bertolucci
JCJoana E. Conti‐Spilari
Joana E. Conti‐Spilari
EOElen Oliveira
Elen Oliveira
ASAnderson J. Simioni
Anderson J. Simioni
MYMihoko Yamamoto
Mihoko Yamamoto